US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Sma Solar Technology (1S) 銘柄情報

Sma Solar Technology (1S)

0.00

0.00

(0.00%)

終了 6月13日 12:30AM

Sma Solar Technology (1S) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

15.46 52 週間の範囲 70.10

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

161,007 €

発行済株式数

34,700,000

配当利回り

PER

-9.04

1 株当たり利益 (EPS)

-5.43

歳入

1.53B

純利益

-188.29M

SMA Solar Technology AG, together with its subsidiaries, develops, produces, and sells PV and battery inverters, monitoring systems for PV systems, and charging solutions for electric vehicles in Germany and internationally. The company operates in two segments: Home & Business Solutions and Large S... SMA Solar Technology AG, together with its subsidiaries, develops, produces, and sells PV and battery inverters, monitoring systems for PV systems, and charging solutions for electric vehicles in Germany and internationally. The company operates in two segments: Home & Business Solutions and Large Scale & Project Solutions. It offers solar and battery inverters, hybrid inverters, system solutions and packages, solar batteries, e-mobility charging solutions, energy management solutions, SMA echarger and commercial storage solutions, and Sunny Tripower X, as well as digital solutions to design, operate, and service PV systems and energy systems. The company serves electric utility companies, independent power producers, project developers and institutional investors, EPCs, system integrators, and grid operators, as well as energy-intensive industries. The company was formerly known as SMA Technologie AG and changed its name to SMA Solar Technology AG in June 2008. SMA Solar Technology AG was founded in 1981 and is headquartered in Niestetal, Germany. 詳細を表示

セクター

Technology

業界

Semiconductors And Equipment

ウェブサイト

www.sma.de

本社

Niestetal, Germany

設立

1981

Sma Solar Technology is listed in the Technology sector of the イタリア証券取引所 with ticker 1S. The last closing price for Sma Solar Technology was -. Over the last year, Sma Solar Technology shares have traded in a share price range of 15.46 € to 70.10 €.

Sma Solar Technology currently has 34,700,000 shares in issue. Sma Solar Technology has a price to earnings ratio (PE ratio) of -9.04.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	59.85	60.6	50.95	580	57.02933563	DE
4	0	0	63.7	70.1	50.95	540	63.63156433	DE
12	0	0	37.46	70.1	36.76	574	56.54313354	DE
26	0	0	37.38	70.1	31.1	462	48.03299441	DE
52	0	0	19.22	70.1	15.46	482	34.47509532	DE
156	0	0	54.35	70.1	11.05	534	26.85036805	DE
260	0	0	54.35	70.1	11.05	534	26.85036805	DE

1S - Frequently Asked Questions (FAQ)

What is the current Sma Solar Technology share price?

The current share price of Sma Solar Technology is 0.00 €

How many Sma Solar Technology shares are in issue?

Sma Solar Technology has 34,700,000 shares in issue

What is the 1 year trading range for Sma Solar Technology share price?

Sma Solar Technology has traded in the range of 15.46 € to 70.10 € during the past year

What is the PE ratio of Sma Solar Technology?

The price to earnings ratio of Sma Solar Technology is -9.04

What is the cash to sales ratio of Sma Solar Technology?

The cash to sales ratio of Sma Solar Technology is 1.11

What is the registered address of Sma Solar Technology?

The registered address for Sma Solar Technology is Sonnenallee 1, Niestetal, Hessen, 34266

What is the Sma Solar Technology website address?

The website address for Sma Solar Technology is www.sma.de

Which industry sector does Sma Solar Technology operate in?

Sma Solar Technology operates in the Semiconductors and Equipment sector

Talisman33

Talisman33 6分前

Ask Amazon? More like ask why they don't sell Lunar on Amazon. Did something happen when they tried selling Acute/Defense with them?

SovereignNinja5

SovereignNinja5 12分前

LMAO ok Beer, I know where you get your info. Send my regards. PBM decisions are not what you think.
This is cute.
“Amarin's benefit from the science will come from Europe and ROW, and Guideline upgrades in those regions.”

The OUS Revenue Reality Check
Looking a

iHub News

iHub News 15分前

BofA’s Hartnett Warns Bullish Positioning Remains Entrenched Despite 5% Bond YieldsJune 13, 2026 7:00 AM
IH Market News

iHub News

iHub News 15分前

BofA’s Hartnett Warns Bullish Positioning Remains Entrenched Despite 5% Bond YieldsJune 13, 2026 7:00 AM
IH Market News

Implanting

Implanting 17分前

There's a lot of uncertainty around how this negotiations process with the First Nations even works. Unless you're in the mine start-up business, it's a long, sorted process between the potential miner, government agencies, and the Natives. These community votes may be in most part "window dressing"

brazen22

brazen22 20分前

Doc, the issue is not whether the SAP included bias checks. Of course it did. The issue is whether those checks were sufficient to prove the external control population was comparable enough to support treatment effect.

Bias checks can reduce concern, but they do not create randomizat

FooBarAndGrill

FooBarAndGrill 20分前

Yes. Quite entertaining.
https://www.linkedin.com/feed/update/urn:li:activity:7470142453950447616/

ITYS

Yes, yes ...we all know what the bid and ask are.
You’re explaining mechanics like that’s the issue here, when the real problem is you’re trying to apply big-float logic to a 9.7M float. That’s why your whole “we need volume every day” argument falls apart.

You keep talking lik

nicehit

nicehit 26分前

Umm, they say Quantum was 20 years away. It's here today. Fusion is coming, and both (Fusion/Nuclear) will co-exist!

yielddude

yielddude 29分前

Congrats SteveSchiets! And to Nsom as well. And thanks again to Sskillz1 for running these contests.

gerry57

gerry57 31分前

I recognize your name from another board . Let’s hope this ceo is far more competent and trustworthy, this moa while different tries to accomplish the same sort of endgame, a neuron closer to homeostasis .

US Market News

US Market News 45分前

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myelomaJune 13, 2026 6:33 AM
PR Newswire (US)

band aid

band aid 45分前

She said after the New Year we would learn more. Got to cut her some slack LOL it's only mid June. Maybe she meant Christmas in July. Anyway you look at it it's a new start up company that takes a lil time to raise capital to buy relish for the hotdog stand.

Investor082

Investor082 50分前

Gary, Eden won’t be certified for commercial production until 2028 at the earliest. That too is highly uncertain and unlikely given NWBO’s history. In fact, its more likely they abandon the project or find some excuse to stall in 2027 than a commercial certification of Eden in 2028.

W

TRAPPER JIM

TRAPPER JIM 54分前

I got all the ceilings downstairs painted except for the kitchen and the bathroom last night. So the only ceilings I have left to paint now are the kitchen, bathroom, one closet and the laundry room. And I’m not sure about the garage ceiling. I need to look at it today. Just thought about that one.

Investor082

Investor082 56分前

“No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA approval for years or until they complete additional trials.”

- I agree with that. This is why no institutiona

US Market News

US Market News 60分前

Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United StatesJune 13, 2026 6:22 AM
Business Wire Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together refer

StockItOut

StockItOut 1時間前

Now how do you know that?

“BOXABL has actually been in contact with XERI.”

.

Investor082

Investor082 1時間前

LOL, no excuses when Flaskworks is not certified for commercial production this year and then again next year, OK?

Anything else is just fluff at this point. It will again prove they are desperate to PR anything and that more importantly UK decision is many months away.

cottonisking

cottonisking 1時間前

Lehman Brothers and Reality (Class 10B payday ?): 14 sites Reality is the totality of all things that exist, independent of whether we are aware of them, believe in them, or understand them. While that definition sounds simple, how reality actually operates depends entirely on the lens—scientific, p

Ranb2khz

Ranb2khz 1時間前

Pentagon releases third batch of UFO files, including civilian videos

~ by www.christianpost.com/by/cp-staff CP Staff , June 13, 2026
____________

The Pentagon released its third batch of files related to unidentified anomalous phenomena (UAPs) or UFOs on Frida

SCAMBUSTERKING

SCAMBUSTERKING 1時間前

You are the only shareholder, this board exists solely to ensure no more shareholders are created.

US Market News

US Market News 1時間前

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free SurvivalJune 13, 2026 6:00 AM
Business Wire - f

Ranb2khz

Ranb2khz 2時間前

In Other News: Google Security Layoffs, AudiA6 Takedown, $400 Million Coupang Fine

~ Other noteworthy stories that might have slipped under the radar: ICS device exposure remains flat as attack surface widens, Microsoft issues incident response playbook for AI, IBM and AT&T accused of

Sma Solar Technology

Kraig Biocraft Laborator... (QB)

Deferred Settlement Trad...

SRJ Technologies

Franklin Templeton Inves...

Scotgold Resources

MFS Charter Income

Ci Canadian Dividend Fun...

Air New Zealand

Deutsche Telekom Interna...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。